Definitions

from Wiktionary, Creative Commons Attribution/Share-Alike License

  • n. Plural form of drugmaker.

Etymologies

Sorry, no etymologies found.

Examples

  • ROBERT SIEGEL, host: Another element of the president's proposal would make it harder for brand name drugmakers to protect their medicines from competition.

    New Powers Would Let FTC Regulate Pharma Deals

  • I think it's interesting to note that neither the generic drugmakers nor the brand name drugmakers support a change.

    New Powers Would Let FTC Regulate Pharma Deals

  • SIEGEL: I understand that the brand name drugmakers are a pretty well defined community.

    New Powers Would Let FTC Regulate Pharma Deals

  • There are so many good generic blood pressure drugs that it is difficult for brand-name drugmakers to improve upon them.

    America's Most Popular Drugs

  • Between 1991 and 1997, the companies that belong to the Pharmaceutical Research and Manufacturers of America PhRMA, the trade group for brand-name drugmakers, gave $18.6 million in political contributions.

    Had Enough?

  • Consumer groups and the generic-drug industry asked Congress to eliminate this windfall for brand-name drugmakers.

    Had Enough?

  • Another concern Klobuchar cited is "pay-for-delay" deals in which brand-name drugmakers pay generic drug companies, often via lawsuit settlements, to keep cheaper generics off the market for a time.

    www.startribune.com

  • The New York-based company, which sells blockbuster blood thinner Plavix, lobbied to oppose banning patent settlements between brand-name drugmakers and generic companies.

  • As for the letters congressional committees are sending the supercommittee, Harkin's suggests saving money by giving brand-name drugmakers fewer years of patent protection against generic competitors and encouraging students to take education loans directly from their colleges - both policies that have been favored by the Obama administration.

    Yahoo! News: Business - Opinion

  • Gal, for instance, believes there is not enough money in biosimilars to justify all of the brand-name drugmakers that are entering the market, a group that includes Eli Lilly

    Forbes.com: News

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.